NCT04554303View on ClinicalTrials.gov

Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential Hypertension

UnknownOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

October 28, 2020

Primary Completion Date

May 23, 2022

Study Completion Date

May 23, 2022

Conditions
Essential Hypertension
Interventions
DRUG

S-amlodipine 2.5mg

Oral administration, 1 tablet per day

DRUG

Amlodipine 5mg

Oral administration, 1 tablet per day

Trial Locations (1)

08308

RECRUITING

Korea University Guro Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Korea University Guro Hospital

OTHER

collaborator

Dt&Sanomedics

INDUSTRY

lead

Ahn-Gook Pharmaceuticals Co.,Ltd

INDUSTRY

NCT04554303 - Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential Hypertension | Biotech Hunter | Biotech Hunter